Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325

Reference

Title : Advances in prodrug design for Alzheimer's disease: the state of the art - Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325
Author(s) : Travers-Lesage V , Mignani SM , Dallemagne P , Rochais C
Ref : Expert Opin Drug Discov , 17 :325 , 2022
Abstract : Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325
ESTHER : Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325
PubMedSearch : Travers-Lesage_2022_Expert.Opin.Drug.Discov_17_325
PubMedID: 35089846

Related information

Citations formats

Travers-Lesage V, Mignani SM, Dallemagne P, Rochais C (2022)
Advances in prodrug design for Alzheimer's disease: the state of the art
Expert Opin Drug Discov 17 :325

Travers-Lesage V, Mignani SM, Dallemagne P, Rochais C (2022)
Expert Opin Drug Discov 17 :325